• info@inflammation-systemicenzymes.com

What is Peyronie’s Disease? – Peyronie’s Disease and Systemic Enzymes

Risky treatment options with no guarantee of effectiveness have led to an increasing use of systemic enzyme therapy as a means to alleviate symptoms and improve quality of life. Certain proteolytic (protein digesting) enzymes have been identified to have extremely beneficial actions when applied to the inflammation and fibrin buildup related to this condition. Systemic enzymes, typically taken orally and on an empty stomach, enter directly into the blood stream. Enzymes then circulate throughout the body, acting upon complexes in the blood as well as in tissues and organs.

 

Peyronie’s Disease and Scar Tissue

Read More

Peyronie’s Disease and Inflammation

Read More

Peyronie’s Disease and Pain

Read More
References:
1. Fujita M, Nomura K, Hong K, et al. Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese natto, a popular soybean fermented food in Japan. Biochem Biophys Res Commun. 1993; 197:1340-1347.
2. Moriya N, Nakata M, Nakamura M, et al. Intestinal absorption of serrapeptase (TSP) in rats. Biotechnol Appl Biochem. 1994; 20(1):101-108.
3. Fujita M, Hong K, Ito Y, et al. Thrombolytic Effect of Nattokinase on a Chemically Induced Thrombosis Model in Rat.  Biol Pharm Bull. 1995; 18(10):1387-1391.
Read More
The contents of inflammation-systemicenzymes.com website, including images, graphics, text and other material, are for informational purposes only. The content on the site is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your healthcare professional with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the inflammation-systemicenzymes.com website. If you think you may have a medical emergency, call your doctor or 911 immediately.